Abbott India Q1 net up 71% to Rs 51 cr

Tags: Companies
Drug firm Abbott India today posted 71.42 per cent rise in its net profit to Rs 50.93 crore for the first quarter ended June 30.

The company had posted a net profit of Rs 29.71 crore for the same period of previous fiscal.

Net sales of the company rose to Rs 516.91 crore for the first quarter, as compared to Rs 429.68 crore during the same period of previous fiscal, Abbott India Ltd said in a filing to the BSE.

In 2010, Abbott acquired both the pharmaceutical business of Solvay, which had a presence in India, and Piramal Healthcare Solutions, which was part of Piramal Group.

These transactions made it one of the largest health care companies in the country. It now employs about 14,000 people in India, making it the firm's largest employee base outside the US.

Shares of Abbott India were trading at Rs 2,330 apiece on the BSE, up 7.08 per cent from its previous close.

EDITORIAL OF THE DAY

  • It seems India will overtake Germany to emerge as the fourth largest economy globally by 2022

    There is speculation that India will overtake Germany to emerge as the fourth largest economy globally by 2022.

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Disequilibrium: INDIA’S kill zones

In a curious twist after the 1999 Lok Sabha hustings, ...

Gautam Datt

<b>Newsmaker<b>: Caught in the middle

Historic opportunities can be easily squandered if they are not ...

Kuruvilla Pandikattu

How to cultivate compassion

Imagine the scenario of a fire alarm goes off ...